Thought you might find this interesting.Hi D Thanks for your...

Thought you might find this interesting.

Hi D Thanks for your email to Admedus. Your query was aroundplans to rebuild the shareprice. The management team is very focused on rebuilding the shareprice. Of the highest priority is continuing to deliver strongbusiness performance, that will ultimately drive value creation – to thateffect they are continuing to build sales of ADAPT globally, they are gettingpositive results on the TAVR animal studies and have plans for thecommercialization of this product.  There’s good news in the pipeline, and Wayne is speaking toprospective investors, with a particular focus on attracting new US basedfunds. The fact that we have two very large institutions on the register – SIOand Star Bright (Constellation) who have invested during this period givesconfidence as well.  We empathise with your frustration / concern at the shareprice – and are focused on rebuilding. Kind regards Kyahn   Kyahn Williamson HEAD OF INVESTOR COMMUNICATION   Level 6, 132-136 Albert RoadSouth Melbourne 3205 Mob +61 401 018 828 Tel +61 3 9866 4722 Direct +613 8866 1214Email: [email protected]  Website www.buchanwe.com.au